Correlation Between Viracta Therapeutics and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Puma Biotechnology, you can compare the effects of market volatilities on Viracta Therapeutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Puma Biotechnology.
Diversification Opportunities for Viracta Therapeutics and Puma Biotechnology
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Viracta and Puma is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Puma Biotechnology
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Puma Biotechnology. In addition to that, Viracta Therapeutics is 1.35 times more volatile than Puma Biotechnology. It trades about -0.03 of its total potential returns per unit of risk. Puma Biotechnology is currently generating about 0.01 per unit of volatility. If you would invest 398.00 in Puma Biotechnology on September 14, 2024 and sell it today you would lose (106.00) from holding Puma Biotechnology or give up 26.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Viracta Therapeutics vs. Puma Biotechnology
Performance |
| Timeline |
| Viracta Therapeutics |
| Puma Biotechnology |
Viracta Therapeutics and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Puma Biotechnology
The main advantage of trading using opposite Viracta Therapeutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Viracta Therapeutics vs. Puma Biotechnology | Viracta Therapeutics vs. Iovance Biotherapeutics | Viracta Therapeutics vs. Day One Biopharmaceuticals | Viracta Therapeutics vs. Inozyme Pharma |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |